Thiostrepton • Triple-negative breast cancer • Sonic hedgehog • Breast cancer stem cell Abstract Background/Aim: Triple-negative breast cancer (TNBC) represents a particular clinical challenge because these cancers do not respond to endocrine therapy or other available targeted agents. The lack of effective agents and obvious targets are major challenges in treating TNBC. In this study we explored the cytostatic effect of thiazole ring containing antibiotic drug thiostrepton on TNBC cell lines and investigated the molecular mechanism. Methods: Cell viability was measured by MTT assay. Cell surface marker was monitored by FCM. Western blot was applied to assess the protein expression levels of target genes. Results: We found that thiostrepton remarkably suppressed the CD44+/CD24-stem-like population and sphere exerted its pharmacological action by targeting sonic hedgehog (SHH) signaling pathway. Thiostrepton repressed SHH ligand expression and reduced Gli-1 nuclear localization in TNBC cell line. Furthermore, the downstream target of SHH signaling undergone dose-dependent, rapid, and sustained loss of mRNA transcript level after thiostrepton treatment. Finally, we showed that SHH ligand was essential for maintaining CD44+/CD24-stem-like population in TNBC cell line. Conclusion: We conclude that thiostrepton suppresses the CD44+/CD24-stem-like population through inhibition of SHH signaling pathway. Our results give a new
Inhibition of Sonic Hedgehog Signaling

Introduction
Breast cancer is a highly heterogeneous malignancy that can be grouped into major subtypes. Triple-negative breast cancer (TNBC) is a distinct clinical subtype and accounts for estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2).
often associates with more aggressive behavior, poorer prognosis, and a shorter median time to relapse and death than other forms of breast cancer. Despite the progress achieved in breast cancer therapeutic innovations the TNBC still represents a particular clinical challenge because these cancers do not respond to endocrine therapy or other available treating patients with TNBC.
Thiostrepton, a thiazole ring containing antibiotic, originally isolated from Streptomyces azureus, has been used in veterinary medicine in mastitis caused by gram-negative organisms and in dermatologic disorders. Despite of its antibiotic action, thiostrepton has been shown to induce cell death in a variety of human cancer cell lines. In melanoma cells, thiostrepton Wang et al. reported that micelle-encapsulated thiostrepton reduced the growth rates of in breast cancer, the mechanism of its anticancer activity and its cellular targets remain undetermined.
that the sonic hedgehog (SHH) signaling pathway mediates progression from a non-invasive phenotype to an invasive phenotype in breast cancer. In a clinical breast cancer sample stem cells [10, 11] . Given the results of clinical analysis and the observation that TNBC often pharmacological target in TNBC [12, 13] .
Here, we show that the thiazole ring containing antibiotic drug thiostrepton decreases action of thiostrepton. Using in vitro suspension cell culture systems, we demonstrate that thiostrepton effectively suppresses the proliferation of breast cancer stem cell of TNBC cell results provide evidence for using the antibiotic drug thiostrepton as a potential effective agent that targets SHH signaling pathway in TNBC treatment. 
Materials and Methods
Cell viability and colony formation assay contrast microscopy. For colony formation assay, 5 × 10 3 number of colonies was counted using Adobe Photoshop.
Flow cytometric analysis
and incubated for 30 min on ice. Unstained cells were used for negative control. Cells that only stained
Mammosphere culture of Mammospheres were photographed and counted 10 d after thiostrepton treatment using inverted anti-rabbit). Following incubation in PBS with propidium iodide, coverslips were mounted on slides.
Plasmids and Transfections
was then added to replace the transfection reagent and cells were allowed to grow overnight before use.
Small interfering RNA and Western blot
Two human SHH siRNA oligos and control siRNA oligos were purchased from Genepharma Inc. Western were resuspended in ice-cold RIPA lysis buffer and Western blot analyses were performed as previously Technology, Inc.), Gli-1(Cell Signaling Technology, Inc.), Nanog (Epitomic, Inc.), and GAPDH (Epitomic, Inc.) °C overnight. Protein bands were visualized with enhanced chemiluminescence.
Results
Thiostrepton effectively inhibits proliferation of triple-negative breast cancer cell lines
obvious morphologic change (Fig. 1A) .
of 20 µM the cell viability of all the cell lines tested displayed sharply reduction and there TNBC cell lines was diminished (Table 1) . These results indicate that thiostrepton induces faster cell death in TNBC cell line and it needs higher concentration and longer time to inhibit thiostrepton resulted in dramatically inhibition of colony formation both in TNBC cell lines may have similar sensitivity. Nevertheless, the different results between MTT assay and that thiostrepton is a potent agent that effectively targets TNBC cell lines.
Thiostrepton reduces the CD44+/CD24-stem-like population in TNBC cell lines cells were highly sensitive to thiostrepton treatment, we then investigated if thiostrepton
In vitro thiostrepton treatment inhibition of SHH signaling pathway is at least one of the important pharmalogical actions of thiostrepton.
Thiostrepton decreases CD44+/CD24-stem-like population via down-regulation of SHH ligand
and mammosphere forming ability. Double strand SHH-antisense siRNA and control siRNA were transfected in MDA-MB-231 cells. As anticipated, SHH ligand level was decreased in self-renewal, indicating that SHH ligand might modulate BCSC self-renewal through the of SHH ligand in BCSC, we performed in vitro mammosphere formation assay. The result cells (Fig. 5F ). In conclusion, these results indicate that SHH pathway plays an important regulation of SHH ligand is at least one of the important mechanism that leads to attenuated Discussion targeting SHH signaling pathway in TNBC cell lines. Notably, we found that thiostrepton inhibited SHH signaling pathway through down-regulation of SHH ligand and reduction of nuclear Gli-1. Furthermore, we showed that SHH ligand was important for maintaining TNBC is reported to have characteristics of more frequent recurrence, chemoresistance the thiazole antibiotic thiostrepton effectively inhibited the cell growth of TNBC cell lines.
induces faster cell death in TNBC cell line and thiostrepton is an effective agent that targeted TNBC cells. and bortezomib, etc. in the future. The inhibition effect of thiostrepton on SHH signaling pathway was further validated by the dose-dependent, rapid, and sustained loss of mRNA transcript level of certain target genes of SHH pathway, including CCND1 and N-Myc. Hitherto, the pharmacological action of thiostrepton is not well understood. Evidence has through de novo protein synthesis because thiostrepton fails to repress an ectopic FOXM1 driven by a CMV promoter [5, 33] . It is interesting to note that FOXM1 has been shown to in our study, it raises the possibility that thiostrepton suppresses SHH signaling pathway that other mechanisms have involved, our study shed light on the potential mechanism of Gli-1 nuclear localization is reduced following thiostrepton treatment. Since Gli-1 nuclear study suggested that the inhibition of SHH signaling by thiostrepton might contribute to its anticancer activity.
Targeting stem cell related signaling pathway is supposed to be an effective therapeutic strategy for treatment of TNBC. SHH signal pathway has been shown to play a pivotal role in the maintenance of self-renewal of mammary stem cells [10] . Activation of hedgehog signaling increases breast cancer mammosphere initiating cell number, whereas inhibition of the pathway results in a reduction of these effects. Consistent with the inhibition effect of SHH ligand is an important mechanism that leads to decreased population by thiostrepton treatment. therapeutic implications. To date, there are already a number of clinical trials employing Hh inhibitor, including natural compound cyclopamine and synthetic small molecules in pancreatic, colorectal and breast cancer [38] . However, possible concerns have derived inducing severe side effects. Some clinical trials have been reported to be suspended owing to side effects of Hh inhibitor [28] . As a natural antibiotic, thiostrepton has already used in thiostrepton has been reported recently to be successful delivered by nanoparticles in human in vivo.
Down-regulation of SHH ligand protein level might be one of the mechanisms whereby lines. Our results give a new insight into the mechanism of thiostrepton anti-tumor activity and provide evidence for using thiostrepton as an effective therapeutic method to treat SHH
